News
UK Pharmaceutical Company’s $130m Punt On French Cannabis Patent
PHARMACEUTICAL company Indivior is expanding into medicines for cannabis-related disorders. The London-listed company has agreed an upfront $30m rights deal
PHARMACEUTICAL company Indivior is expanding into medicines for cannabis-related disorders. The London-listed company has agreed an upfront $30m rights deal
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.